Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That's a great analogy ZIplock ....lol.... but if the dog keeps barking at the bush people are eventually going to think the dog has issues .... if AMRN were thinking they would wonder out loud if the dog has issues understanding the existing science ...
YOu can still make money by shorting the buffoons ! The stock isn't broken as much as the company is. It was lead by inexperienced nincompoops who had NO understanding of the business they were in. Their repeated mistakes destroyed a scientifically sound product to the point that the likes of the Baker Bros and now even Denner seem unable to rescue them from their own stupidity and timidity.
Thero and crew should be taught at every business school as the classic example of how a great product can be destroyed by the management of clowns.
Short them down to $1 then wait and see
ANd yet no statin intolerant branch - perfect opportunity ....
Rewarding incompetence and buffoonery is never a good idea ....
Flat salary with rewards for stock performance is the only appropriate course anything else is legalized theft
Thero pumped out millions into his pocket while the company was destroyed
Well I guess i need a few beers to ff your logic as the basis of REDUCE-IT was use with a statin -
BAsed on that logic the block buster lipitor would not sell well because of people who cant use statins
I'd much rather take the statin market than the statin intolerant market
However the buffoons should have had a statin intolerant branch in REDUCE IT - if results were better than statins .... they would have entered a monstrous market - if results were worse - well then its just a statin enhancer - there was nothing to lose ....
You mean its a "Statin Enhancer" hmmmm.... seems I have heard that mentioned here. I'm certain AMRN's outstanding marketing team has thought of this as well .....lol
Once again the buffoons should have marketed this as a satin enhancer - why ?
Because docs know statins
docs rx statins
docs will linnedialey link this with a statin in their thought patterns
Prescribing a statin ? Want 25 % improvement in performance ? Then add a statin enhancer !
Docs will not think of it as just a fish oil
Go to an office and ask to speak to a doc about fish oil or a statin enhancer - which one will open more doors ??
The list goes on and on - but its too late - Docs view this as fish oil - period and no one is going to waste their time and energy prescribing ground up anchovies in the 21st century
Instead of having come up with a marketing strategy we will spend out time energy and resources placing ourselves in a comfy office in Switzerland where we can enjoy the beautiful scenery and all the nice people ....
BUFFOONS !!!
I only wish there was more to short here
Unfortunately, the lesson that was taught here is you can't only look at the science.
If Someone would have said to me 5 years ago:
We have a new product for the Number one killer that will reduce events by 25% on top of current treatments.
I would have responded - If all that is true you have a block buster on your hands .
As we all know, that was true but Thero and Crew and now Mikhail have failed miserably in advancing this product. It is incompetence to the highest degree, an absolute failure to understand the business environment in which they were operating .
MY take away on this: DD not only requires an evaluation of the science it requires an evaluation of CEO capability and experience
One could ask why AMRN never included a statin intolerant arm in the original REDUCE IT study? Just another grave oversight - Can EPA compete directly with statins?
EPA gave 25% reduction on top of statins what would have been the risk reduction before statins took the lions share ?
We already know its a statin enhancer but instead we market it as fish oil - the absolute zenith of business buffoonery
When it comes to AMRN bet on buffoonery but I'm not certain it can go much lower, there is a certain amount of value in Canada Europe CHina etc - but knowing the buffoons they may be able to screw that up as well.
NOnetheless I am hesitant to short this stock any longer.
Quarterly financials
(USD) Mar 2022 Y/Y
Revenue 94.63M Down 33.44%
Net income -31.56M Down 1841.14%
Diluted EPS -0.08 0%
Net profit margin -33.35% Down 2825.44%
Earnings calls
Previous EPS Revenue
Q1 2022 Miss -1,500.00% Miss -26.19%
AMRN clearly should be taught in business schools as a prime example of how having a great product with strong science does not guarantee success if the company is poorly managed. Frankly, AMRN's management has been nonsensical for the most part. Their failure to market correctly, failure to understand medication distribution, failure to understand physician prescribing habits, failure in letting the med be labelled "fish Oil" ,failure in allowing NIssen to repetitively attack them , failure in understanding what venue to have their cases tried, failure to understand generics and that's only the tip of the iceberg ,destroyed what should have been a blockbuster medication. for the # 1 killer Marketing as a 'statin enhancer ' would have opened so many more doors and enabled MD prescribing - this is just one of hundreds of errors.
I realized that the only certainty with AMRN is - buffoonery. I begin to short the stock knowing management would screw it up. I have made most of my money back on this strategy. (Un)fortunately that strategy probably has little play left - unless the entire medial community buys into the mineral oil scenario ( which NIssen may be successful in propagating). If Denner can take over that may help . MY guess is that BB may be talking to Denner and actually may have facilitated him coming on board. I would warn longs not to hang your hat on a single savior like Denner . UNtil such time that I see Denner actually taking the reigns (buy)or NIssen and the medical community buying into the mineral oil issue (short) I will remain on the sidelines.
Ahh yes -- the buffoonery and incompetence of AMRN continues to make me money. With denner taking over I will have to reevaluate that strategy ....
There is only one thing I am certain of with AMRN - it is run by a bunch of incompetent buffoons .... knowing that I shorted and AMRN DID NOT FAIL ME - thank you to the keystone cops of business !!
Sorry for all of you who continue to believe in these grifters ...
Insiders selling big time while biopharmcatalyst site tries to pump - noit a good sign
Legal actions are still proceeding against AMRN and they are not ruling out going beyond management liability insurance coverage levels for Thero and Kennedy
Think about the 1000's of docs not prescribing the drug because of a company that it totally useless. My patients can get it from their cardiologist or endocrinologist who will be managing their CAD or diabetes.
The hassle of the medication has made use unreasonable - I have over a hundred patients that have not gotten the med because of the insurance company etc etc - what do I do for those patients ? statins PCSK9's sglt2's etc. The same as what I will be doing for everyone now. In the ideal world everyone gets the med they need in the real word people are buying dog food instead. Thero was a buffoon and took a company with great science and destroyed it. KM does not seem to be doing any better at this point. Mid level management is next to useless. There is total disorganization in the ranks with people wandering around having no clue as to how to move the company forward and dont give a damn.
If Denner can clean house they may have a chance. If Marjac wins it will give the stock a boost but this company is so totally dysfunctional that I wonder if they will even be able to capitalize on such a gift.
Yes I have lost total respect for the business acumen of anyone associated with AMRN - how anyone could put Thero on a board after such a total and dismal failure of management is beyond me.
I have to agree SHadolane... I have come to the conclusion that this company is full of buffoons - lazy ones at that. I contacted them offering to write an article on Vascepa ( favorable) for publication in a Family Practice JOurnal - NO REPLY !!... Can you imagine a struggling company being offered free advertising via a scientific article to the largest group of prescribers in the country ...and they dont even respond !! I am seriously thinking king of selling once we are back at $4.25 where I will be at break even. I have ceased prescribing the drug and I have ceased doing any Prior Auths
I bought Amazon at the dip and made 13% in one day - my AMRN money is better off doing that
The article is mistaken ...lol Thero did not successfully launch Vascepa - he took a product that had great science and literally destroyed it as a commercial success. Its one of the worst rollouts in biotech history.
AMRN cant even keep their web site up to date . I have never seen a more disorganized, non focused, non responsive, clueless company. Its hard to believe that they were given a great product with solid science and have totally failed as a result of business and legal inadequacies. If we get back to $4.xx I am contemplating taking my money and leaving this loser/ I just bought amazon on the drop and and made 14% in one day so glad I did not even think of AMRN. I have pretty much ceased prescribing the med and I certainly will spend no more time fighting their battles.
Great Letter Capt Beer but unfortunately AMRN is CLUELESS
I actually sent an email to their PR department indicating that I was a doctor and wished to write an article on Vascepa. Basically offering them the chance of free advertisement in a positive light .... NO RESPONSE .... KM needs to clean house .... I dare say I think State Workers are probably more efficient thanh AMRN employees
Problem is getting docs to write what indication its written for ... they tend to just write the Rx
Agree thanks FFS was the buy posted ?
Lizzy ...unicorns and sheroes need a place to stay ....
Pt called and stated Wellcare and the pharm told her she could switch to fish oil instead of vascepa bc her insurance does not cover it, wanted to know if you can change her prescription bc she can not afford it.
I dont fight this anymore i just say OK
Send it to Stevie ...
My guess is the sheroes rode their unicorns into an area where their phones dont get reception ...
Yes Pfizer could an intelligent 8th grader could as well - doesn't say much for AMRN's management - glad they are getting shook down -
Yes she did RMB I recall seeing that she clearly stated that the REDUCE IT indication is patent protected - but as we see - yes its protected but infringing is fine
I seem to remember someone mentioning generics even before REDUCE IT
Ha excellent ! Logic doth run from DU like leaves from the wind ....
Well obviously all the sheroes were out riding unicorns through the daisies --- This is why the law suits are looking at going after Kennedy Thero and others personally ....
I have never placed any value on AMRN for revenues from CHina or Covid ... Even Larger corporations are finding out you dont win in CHina - they will let you enter, lay out the red carpet, watch what you are doing, steal what your are doing, then they dont need you and out the door you go ...
AMRN now a "penny stock" lol
https://www.cnhinews.com/exchange/finance/article_732cc4cf-a330-59f7-993a-34401b412dce.html
good buy Kiwi I was going to buy must admit I felt like It would be sending good money after bad after purchasing at $3.xx and $4.25 so held off
anything that gets the sheroes off the unicorns out of the daisies and into an office is good ....
$12 ....... better than where we are at ... but unless he can produce actual sales that produce actual revenues this is just a ride in SP from hope not substance .....
Irrational Exuberance ??? lol -
Buffoons listening to jesters reciting tales about sheroes riding unicorns through the daisies ... can't understand why the business wont run ... or the country